Several studies have also shown a gradual decrease in IL-6 concentrations over time in patients recovering from COVID-19, suggesting its involvement in the resolution of systemic inflammation and its potential utility as a longitudinal biomarker of recovery [19]. The gene discussed is IL6; the disease is COVID-19.